Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals | COVID-19 Impact Analysis

Global Neurovascular Products Market $3.6 Billion by 2027

The global market for neurovascular products estimated to reach $3.6 billion by 2027, growing at a CAGR of 6.8% over the forecast period, driven by high demand for minimally invasive surgeries, increasing number of patients suffering from neurovascular diseases, and rising geriatric population.

Global Neurovascular Products Market

Endovascular treatment of neurological conditions is a rapidly evolving field that spans across various specialties namely neurosurgery, neuroradiology, neurology, and cardiology and has many names such as endovascular neurosurgery, interventional neuroradiology, and interventional neurology.

  • Endovascular treatments have demonstrated recent advances in reaching the marketplace and providing more options for patients with acute ischemic stroke and intracranial aneurysms specifically.
    • Neurointerventional devices have been the focus of attention recently, with rapid evolution and advancement of treatments, such as mechanical neurothrombectomy devices for stroke and endovascular devices to treat intracranial aneurysms.

Stroke is the most prevalent therapeutic application for neurovascular devices.

  • According to WHO, stroke is the second leading cause of death and a major cause of disability worldwide. Each year, 33 million people worldwide suffer a stroke. Its incidence is increasing because the population ages.
  • Highest prevalence of stroke was observed in Russia and Eastern European countries. Accounting for more than 85% of strokes, ischemic stroke is the most common type of stroke, caused by an obstructed artery that supplies blood to the brain.
    • In addition, more young people are affected by stroke in low- and middle-income countries.
Global stroke prevalence

The global market for neurovascular products (cerebral aneurysm and arteriovenous malformation embolization systems) research report provides market size (Revenue $million 2017 to 2027), market share analysis, growth trends and forecast (CAGR%, 2021 to 2027).

The global market for neurointerventional embolization systems segmented by product [embolization (embolic coils), embolization-enabling stents (flow-diversion stents and intrasaccular devices), mechanical thrombectomy devices, micro guidewires and micro catheters], by application (cerebral aneurysm, cerebral artery stenosis, stroke, others), by end user (ambulatory surgical centers, hospitals, clinics) and geography.

  • Currently, there are several devices with market authorization for preventing and treating stroke.
    • Embolic coiling is the established gold standard for treating cerebral aneurysms. Coiling is the most established and successful product line in the neurovascular field and sales are likely to remain high.
  • The global neurovascular products market is led by embolic coils segment.
    • Factors such as lower cost, innovative products and strong clinical data clearly demonstrating the superiority of embolic coiling over surgical clipping are supporting the steady growth of embolics segment.
  • Globally increasing incidence of stroke, coupled with rising geriatric population at the risk of neurovascular diseases is expected to boost the demand for neurointerventional products in the coming years.
    • Cerebral aneurysm is projected to be the fastest-growing therapeutic application over the forecast period.

The global neurovascular devices market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

  • In terms of geography, the North America region accounted for the largest share of the total cerebral aneurysm and arteriovenous malformation (AVM) embolization systems market and is likely to retain the top position over the forecast period.
    • Key factors driving growth include availability and acceptance of wide product range, advanced technologies with higher efficiency and reliability, and favorable reimbursement policies.
  • On the other hand, the Asia Pacific region is the fastest-growing region, where Japan is projected to maintain a leading position over the forecast period, owing to increasing awareness about neurovascular diseases and its management.

In addition, the global market for neurointerventional embolization systems report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries.  The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

Major competitors operating in the global neuro-interventional products market and profiled in this report include Johnson & Johnson, Medtronic plc, Penumbra, Inc., Stryker Corporation, and Terumo Corporation. Other competitors include Abbott Laboratories, Inc., Boston Scientific Corporation, Merit Medical Systems, Inc., MicroPort Scientific Corporation, and W. L. Gore & Associates, Inc.

  • Product
    • Embolization (Embolic Coils)
    • Embolization-enabling Stents (Flow-diversion Stents and Intrasaccular Devices)
    • Mechanical Thrombectomy Devices
    • Micro Guidewires and Micro Catheters
  • Application
    • Cerebral Aneurysm
    • Cerebral Artery Stenosis
    • Stroke
    • Others
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Clinics
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • Abbott Laboratories, Inc.
    • Boston Scientific Corporation
    • Johnson & Johnson
    • Medtronic plc
    • Merit Medical Systems, Inc.
    • MicroPort Scientific Corporation
    • Penumbra, Inc.
    • Stryker Corporation
    • Terumo Corporation
    • W.L. Gore & Associates, Inc.

To request Table of Contents and Sample Pages of this report visit:

Related publications:

    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]



    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: [email protected]